NVS

Novartis AG - ADR

Halal Rating :
Comfortable
Last Price $97.08 Last updated:
Market Cap $216.2b
7D Change -1.3%
1 Year Change -1.04%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 29, 2024

Novartis AG researches, develops, manufactures, and markets healthcare products. The company operates through two segments, Innovative Medicines and Sandoz. Sandoz provides finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
June 30, 2024 $12.51b $8.83b - $246.0m 0.00% 2.79%
March 31, 2024 $11.83b $8.42b $6.0m $221.0m 0.05% 2.62%
Dec. 31, 2023 $11.78b $9.41b - $217.0m 0.00% 2.31%

Company Impact

Help us evaluate Novartis AG - ADR's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates